Odense University Hospital
Odense, 5000, Denmark
NCT Number: NCT02445365
Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease (IBD). At the time of diagnosis it is not possible to predict the course of the disease, which can range from a few flares in a lifetime to uncontrollable disease leading to hospitalization, surgery and stoma. There is a continuous need to improve treatment as well as diagnostic and prognostic tools.
This study evaluates the clinical efficacy, tolerability and feasibility of remote ischemic conditioning (RIC) in patients with moderate active ulcerative colitis (UC). The investigators hypothesize that RIC beyond the well known effect on reperfusion tissue damage has a clinically relevant anti-inflammatory effect in UC. RIC constitute a repeated brief and non-harmful suppression of blood circulation in a limb. The mechanism of action of RIC is likely to involve suppressed inflammation and cell death.
Our study is a randomized clinical controlled study including 38 patients. Patients will receive RIC or sham for 10 consecutive days.
The effect of RIC on active UC is evaluated by changes patient's symptoms, endoscopy findings, and various markers in the blood, faeces and the intestinal wall.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Interventional
Not applicable
Odense, 5000, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Time frame: 10 days
Odense University Hospital
Other
Effect of Remote Ischemic Conditioning (RIC) on Inflammation and Remodelling of Extracellular Matrix Proteins in Patients With Inflammatory Bowel Diseases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02647866
Abdominal Pain, Autoimmune Disease
Greenville, South Carolina, United States
View Trial DetailsNCT07102368
Colitis, Colitis, Ulcerative
Berlin, Germany
View Trial DetailsNCT02569333
Colitis, Colitis, Ulcerative
Toronto, Ontario, Canada
View Trial DetailsNCT04647578
Colitis, Colitis, Ulcerative
Lille, France
View Trial Details